Related Experiment Video
Updated: Jul 5, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Risk factors for potential drug interactions in general practice
Lars Bjerrum1, Beatriz Gonzalez Lopez-Valcarcel, Gert Petersen
1Research Unit and Department of General Practice, University of Southern Denmark, Odense, Denmark. lbjerrum@health.sdu.dk
The European Journal of General Practice
|May 9, 2008
Summary
High age, polypharmacy, and multiple prescribers increase the risk of potential drug interactions. Identifying these patient and practice factors is key for improving medication safety.
Area of Science:
- Pharmacoepidemiology
- Drug safety research
- Health services research
Background:
- Concurrent use of multiple medications (polypharmacy) is common and can lead to potential drug interactions.
- Identifying factors associated with these interactions is crucial for patient safety and effective healthcare delivery.
- General practices serve as a primary point of care, making them ideal settings to study drug interaction risks.
Purpose of the Study:
- To identify patient-specific and general practice-related factors linked to potential drug interactions.
- To investigate the prevalence of polypharmacy and associated drug interactions within a defined population.
- To inform quality improvement initiatives aimed at reducing medication-related adverse events.
Main Methods:
- A register analysis was conducted using prescription data from the Odense University Pharmacoepidemiologic Database (OPED) in Funen, Denmark.
- The study identified individuals using two or more drugs concurrently (polypharmacy) and classified potential drug interactions by severity.
- A two-level random coefficient logistic regression model analyzed patient and practice factors associated with drug interactions.
Main Results:
- Approximately one-third of the population experienced polypharmacy, with 6% exposed to potential drug interactions annually.
- Patient factors increasing interaction risk included advanced age, a high number of concurrently used drugs, and multiple prescribers.
- Practice factors associated with higher interaction risk were a large proportion of elderly patients and a low proportion of female patients.
Conclusions:
- Prescription data analysis effectively identifies patient and practice groups at elevated risk of drug interactions.
- Findings can guide targeted interventions within quality improvement programs to enhance medication safety.
- Understanding these risk factors is essential for proactive management of polypharmacy and prevention of adverse drug events.
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...